[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Orthopedic Regenerative Surgical Products Market Size, Share & Trends Analysis Report By Product (Allograft, Synthetic, Cell-based, Viscosupplements), By Application, By End Use, By Region, And Segment Forecasts, 2022 - 2030

February 2022 | 150 pages | ID: OC484F3B4980EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within Immediate

Orthopedic Regenerative Surgical Products Market Growth & Trends

The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 3.9% from 2022 to 2030. The key factors driving the market growth include the rising geriatric population, orthopedic procedures, research activities, and technological advancements. Osteoarthritis, for instance, has been identified as the leading cause of chronic disability in the geriatric population over the age of 70. The World Health Organization (WHO) has also designated osteoarthritis as a ‘priority disease’ promoting R&D for therapies to treat osteoarthritis and its associated symptoms.

The growth of the market was restrained during the COVID-19 pandemic due to deferred elective surgeries, low volume of patient flow for chronic conditions in clinics and hospitals, decreased sales and marketing activities, quarantine and lockdown protocols, and low demand. Vericel Corporation, for example, reported the adverse impact of COVID-19 on its business and operations during 2020. The company registered cancellations of scheduled MACI procedures; its key product used in the repair of cartilage damage of the knee. In addition, there was a slowdown in new orders. Anika Therapeutics reported challenges in patient enrollment for its clinical trials due to the pandemic, which negatively impacted the company’s revenue and operating results. However, both companies expect recovery financial performance as elective surgeries resumes to pre-COVID numbers.

According to the Centers for Disease Control and Prevention (CDC), about 26% (or 78 million) the U.S. adults are estimated to suffer from arthritis by 2040. The prevalence increases with age and is found to be more common in women. Obesity has been identified as another risk factor contributing to orthopedic conditions. The prevalence of obesity in the U.S. was estimated at 42.4% from 2017 to 2018 by the CDC. The increasing prevalence of orthopedic diseases, obesity, and geriatric population is expected to fuel market growth. Orthopedic regenerative surgical products find application in different conditions of varying severity from joint pain, gout, articular defects, fibromyalgia, and osteoarthritis, to trauma and joint replacement, this is expected to contribute to market growth.

Market players are also involved in research and development activities to launch new regenerative solutions for treatment or pain relief from orthopedic conditions. Amniox Medical, Inc. for instance, received FDA clearance to proceed with a dosing study using TTAX03- its Investigational New Drug (IND) comprising cryopreserved amniotic membrane and umbilical cord, to treat facet joint osteoarthritis pain in March 2021. Zimmer Biomet on the other hand offers an extensive portfolio of allografts and synthetic orthopedic regenerative products such as the PrimaGen Advanced allograft, InterGro DBM, and PlatFORM bioresorbable bone graft substitute.

Orthopedic Regenerative Surgical Products Market Report Highlights
  • Key factors driving the market include an aging population across the globe and a rise in the prevalence of orthopedic diseases. According to a 2019 review article published in the Elderly Health Journal, the prevalence of knee osteoarthritis in various Asian countries was found to be in a range of 13.1 - 71.1%
  • The viscosupplements segment dominated the market and accounted for the largest revenue share of over 42.0% in 2021 owing to the increasing prevalence of osteoarthritis and related symptoms and product availability
  • Monovisc and Orthovisc by Anika Therapeutics are the leading products in the viscosupplement market in the U.S. since 2018, based on combined overall revenue
  • In terms of application, the cartilage and tendon repair segment is estimated to witness the fastest CAGR of 4.1% owing to growing applications in sports medicine, geriatric patients, and the incidence of trauma cases
  • According to a 2019 study on Cartilage Restoration Surgery published by the National Library of Medicine, complications in cartilage restoration procedures have been rising for the past 2 decades. The results also indicated a paradigm shift toward osteochondral grafting procedures and other more complex cartilage procedures
  • As most orthopedic procedures are performed within hospital settings, the hospitals segment held the largest revenue share of over 49.0% in 2021
  • Drivers include a large number of populations affected by joint pain and other debilitating orthopedic conditions and supportive initiatives by governments and regulatory bodies. For example, 12 October was established as the World Arthritis Day by the Arthritis and Rheumatism International (ARI)to raise awareness about rheumatic and musculoskeletal diseases
  • Market players are involved in the implementation of strategic initiatives, including R&D, product development and launches, regional expansion, and expansion of distribution network
  • In January 2021, Stryker acquired OrthoSensor, Inc., a private company that specializes in musculoskeletal care and sensor technology
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market Segmentation and Scope
  1.1.1 Segment Scope
  1.1.2 Regional Scope
  1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Research Assumptions
1.4 Information Procurement
  1.4.1 Purchased Database
  1.4.2 Gvr’s Internal Database
  1.4.3 Secondary Sources
  1.4.4 Primary Research
  1.4.5 Details Of Primary Research
1.5 Information Or Data Analysis
  1.5.1 Market Formulation & Validation
  1.5.2 Data Analysis Models
1.6 Market Formulation & Validation
  1.6.1 Primary Validation
1.7 Model Details
  1.7.1 Commodity Flow Analysis
1.8 List Of Secondary Sources

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Orthopedic Regenerative Surgical Products Market Summary

CHAPTER 3 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Lineage Outlook
  3.1.1 Parent Market Analysis
  3.1.2 Ancillary Market Analysis
3.2 Orthopedic Regenerative Surgical Products Market Dynamics
  3.2.1 Market Driver Analysis
  3.2.2 Market Restraint Analysis
  3.2.3 Market Opportunity Analysis
  3.2.4 Market Challenge Analysis
3.3 Penetration And Growth Prospect Mapping, 2021
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  3.4.1 Political & Legal
  3.4.2 Economic Landscape
  3.4.3 Technology Landscape
3.5 Orthopedic Regenerative Surgical Products Market Analysis Tools: Porters
  3.5.1 Bargaining Power Of Suppliers: Low To Moderate
  3.5.2 Bargaining Power Of Buyers: Moderate
  3.5.3 Threat Of Substitutes: High
3.6 Regulatory Framework
  3.6.1 FDA Consideration
  3.6.2 Reimbursement Framework
  3.6.3 HCPCS Coding
3.7 Technology Trend Analysis
3.8 Product Pipeline Analysis
3.9 Orthopedic Disease Prevalence
  3.9.1 Estimated Hip Surgery Procedure Volumes By Country (2016 - 2028, Units)
  3.9.2 Estimated Knee Surgery Procedure Volumes By Country (2016 - 2028, Units)

CHAPTER 4 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET: COVID-19 IMPACT ANALYSIS

4.1 Covid-19 Impact Analysis
  4.1.1 Disease Prevalence Analysis
  4.1.2 Current Impact Analysis
  4.1.3 Future Impact Analysis
  4.1.4 Impact On Market Players

CHAPTER 5 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET: SEGMENT ANALYSIS, BY PRODUCT, 2017 - 2030 (USD MILLION)

5.1 Product Market Share Analysis, 2021 & 2030
5.2 Orthopedic Regenerative Surgical Products Market, by Product, 2017 to 2030
5.3 Allograft
  5.3.1 Allograft Market, 2017 - 2030 (USD Million)
  5.3.2 Amniotic Products
    5.3.2.1 Amniotic Products Market, 2017 - 2030 (USD Million)
  5.3.3 Others
    5.3.3.1 Others Market, 2017 - 2030 (USD Million)
5.4 Synthetic
  5.4.1 Synthetic Market, 2017 - 2030 (USD Million)
5.5 Cell-based
  5.5.1 Cell-Based Market, 2017 - 2030 (USD Million)
5.6 Viscosupplements
  5.6.1 Viscosupplement Market, 2017 - 2030 (USD Million)

CHAPTER 6 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET ANALYSIS, BY APPLICATION, 2017 - 2030, (REVENUE, USD MILLION)

6.1 Application Market Share Analysis, 2021 & 2030
6.2 Orthopedic Regenerative Surgical Products Market, by Application, 2017 to 2030
6.3 Orthopedic Pain Management
  6.3.1 Orthopedic pain management market estimates and forecasts, 2017 - 2030 (USD Million)
6.4 Trauma
  6.4.1 Trauma market estimates and forecasts, 2017 - 2030 (USD Million)
6.5 Cartilage and Tendon Repair
  6.5.1 Cartilage and tendon repair market estimates and forecasts, 2017 - 2030 (USD Million)
6.6 Arthroplasty/Joint Reconstruction
  6.6.1 Arthroplasty/joint reconstruction market estimates and forecasts, 2017 - 2030 (USD Million)
6.7 Others
  6.7.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

CHAPTER 7 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET: SEGMENT ANALYSIS, BY END-USE, 2017 - 2030 (USD MILLION)

7.1 End-use Market Share Analysis, 2021 & 2030
7.2 Orthopedic Regenerative Surgical Products Market, By End Use, 2017 to 2030
7.3 Hospitals
  7.3.1 Hospitals market estimates and forecasts, 2017 - 2030 (USD Million)
7.4 Ambulatory Surgery Centers
  7.4.1 Ambulatory surgery center market estimates and forecasts, 2017 - 2030 (USD Million)
7.5 Others
  7.5.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)

CHAPTER 8 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET: REGIONAL MARKET ANALYSIS 2017 - 2030 (USD MILLION)

8.1 Regional Market Share Analysis, 2021 & 2030
8.2 Regional Market Snapshot
8.3 North America
  8.3.1 North America orthopedic regenerative surgical products market estimates and forecasts, 2017 - 2030 (USD Million)
  8.3.2 U.S.
    8.3.2.1 U.S. orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.3.3 Canada
    8.3.3.1 Canada Orthopedic Regenerative Surgical Products Market, 2017 - 2030 (USD Million)
8.4 Europe
  8.4.1 Europe Orthopedic Regenerative Surgical Products Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  8.4.2 U.K.
    8.4.2.1 U.K. orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.4.3 Germany
    8.4.3.1 Germany orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.4.4 France
    8.4.4.1 France orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.4.5 Italy
    8.4.5.1 Italy orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.4.6 Spain
    8.4.6.1 Spain orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
8.5 Asia Pacific
  8.5.1 Asia Pacific orthopedic regenerative surgical products market estimates and forecasts, 2017 - 2030 (USD Million)
  8.5.2 Japan
    8.5.2.1 Japan orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.5.3 China
    8.5.3.1 China orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.5.4 India
    8.5.4.1 India orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
8.6 Latin America
  8.6.1 Latin America orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.6.2 Brazil
    8.6.2.1 Brazil Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
  8.6.3 Mexico
    8.6.3.1 Mexico Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
  8.6.4 Argentina
    8.6.4.1 Argentina Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
8.7 MEA
  8.7.1 MEA orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
  8.7.2 South Africa
    8.7.2.1 South Africa Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
  8.7.3 Saudi Arabia
    8.7.3.1 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)

CHAPTER 9 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET - COMPANY PROFILES

9.1 Company Profiles
  9.1.1 BAXTER
    9.1.1.1 Company Overview
    9.1.1.2 Financial performance
    9.1.1.3 Product benchmarking
    9.1.1.4 Strategic initiatives
  9.1.2 ZIMMER BIOMET
    9.1.2.1 Company Overview
    9.1.2.2 Financial performance
    9.1.2.3 Product benchmarking
    9.1.2.4 Strategic initiatives
  9.1.3 STRYKER
    9.1.3.1 Company Overview
    9.1.3.2 Financial performance
    9.1.3.3 Product benchmarking
    9.1.3.4 Strategic initiatives
  9.1.4 SMITH+NEPHEW
    9.1.4.1 Company Overview
    9.1.4.2 Financial performance
    9.1.4.3 Product benchmarking
    9.1.4.4 Strategic initiatives
  9.1.5 ALLOSOURCE
    9.1.5.1 Company Overview
    9.1.5.2 FINANCIAL PERFORMANCE
    9.1.5.3 Product benchmarking
    9.1.5.4 Strategic initiatives
  9.1.6 AMNIOX MEDICAL, INC.
    9.1.6.1 Company Overview
    9.1.6.2 FINANCIAL PERFORMANCE
    9.1.6.3 Product benchmarking
    9.1.6.4 Strategic initiatives
  9.1.7 ANIKA THERAPEUTICS, INC.
    9.1.7.1 Company Overview
    9.1.7.2 Financial performance
    9.1.7.3 Product benchmarking
    9.1.7.4 Strategic initiatives
  9.1.8 VERICEL CORPORATION
    9.1.8.1 Company Overview
    9.1.8.2 Financial performance
    9.1.8.3 Product benchmarking
    9.1.8.4 Strategic initiatives
  9.1.9 VSY BIOTECHNOLOGY GMBH
    9.1.9.1 Company Overview
    9.1.9.2 FINANCIAL PERFORMANCE
    9.1.9.3 Product benchmarking
    9.1.9.4 Strategic initiatives
  9.1.10 APTISSEN S.A
    9.1.10.1 Company Overview
    9.1.10.2 Financial performance
    9.1.10.3 Product benchmarking
    9.1.10.4 Strategic initiatives
  9.1.11 MIMEDX
    9.1.11.1 Company Overview
    9.1.11.2 Financial performance
    9.1.11.3 Product benchmarking
    9.1.11.4 Strategic initiatives
9.2 Market Participant Categorization
9.3 Public Companies
  9.3.1 INNOVATORS
  9.3.2 MARKET LEADERS
  9.3.3 COMPANY MARKET POSITION ANALYSIS
  9.3.4 SYNERGY ANALYSIS: MAJOR DEALS & STRATEGIC ALLIANCES
9.4 Private Companies
  9.4.1 LIST OF PRIVATE COMPANIES

LIST OF TABLES

Table 1 List of secondary sources
Table 2 List of the key regulations, directives by countries
Table 3 List of private companies
Table 4 North America orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 5 North America orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 6 North America orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 7 North America orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 8 U.S. orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 9 U.S. orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 10 U.S. orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 11 U.S. orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 12 Canada orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 13 Canada orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 14 Canada orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 15 Canada orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 16 Europe orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 17 Europe orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 18 Europe orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 19 Europe orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 20 UK orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 21 UK orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 22 UK orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 23 UK orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 24 Germany orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 25 Germany orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 26 Germany orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 27 Germany orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 28 France orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 29 France orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 30 France orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 31 France orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 32 Italy orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 33 Italy orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 34 Italy orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 35 Italy orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 36 Spain orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 37 Spain orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 38 Spain orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 39 Spain orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 40 Asia Pacific orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 41 Asia Pacific orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 42 Asia Pacific orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 43 Asia Pacific orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 44 Japan orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 45 Japan orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 46 Japan orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 47 Japan orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 48 China orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 49 China orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 50 China orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 51 China orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 52 India orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 53 India orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 54 India orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 55 India orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 56 Latin America orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 57 Latin America orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 58 Latin America orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 59 Latin America orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 60 Brazil orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 61 Brazil orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 62 Brazil orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 63 Brazil orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 64 Mexico orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 65 Mexico orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 66 Mexico orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 67 Mexico orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 68 Argentina orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 69 Argentina orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 70 Argentina orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 71 Argentina orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 72 MEA orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 73 MEA orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 74 MEA orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 75 MEA orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 76 South Africa orthopedic regenerative surgical products market, by component, 2017 - 2030 (USD Million)
Table 77 South Africa orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 78 South Africa orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 79 South Africa orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 80 South Africa orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
Table 81 Saudi Arabia orthopedic regenerative surgical products market, by product, 2017 - 2030 (USD Million)
Table 82 Saudi Arabia orthopedic regenerative surgical products market, by allografts, 2017 - 2030 (USD Million)
Table 83 Saudi Arabia orthopedic regenerative surgical products market, by application, 2017 - 2030 (USD Million)
Table 84 Saudi Arabia orthopedic regenerative surgical products market, by end-use, 2017 - 2030 (USD Million)
LIST OF FIGURES

Fig. 1 Orthopedic Regenerative Surgical Products market segmentation
Fig. 2 Methodology
Fig. 3 Market research process
Fig. 4 Data triangulation techniques
Fig. 5 Primary research pattern
Fig. 6 Primary research pattern
Fig. 7 Market research approaches
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Orthopedic Regenerative Surgical Products Market outlook (2021, USD Million)
Fig. 12 Parent market analysis
Fig. 13 Ancillary market analysis
Fig. 14 Orthopedic regenerative surgical products market dynamics analysis
Fig. 15 Orthopedic regenerative surgical products market driver analysis
Fig. 16 Common causes of spinal injury, 2018
Fig. 17 Orthopedic regenerative surgical products market restraint impact
Fig. 18 Penetration & growth prospect mapping by end-use, 2021
Fig. 19 Ortho regenerative technologies: Product pipeline analysis
Fig. 20 COVID-19 confirmed cases around the world
Fig. 21 Orthopedic Regenerative Surgical Products market: Product movement analysis
Fig. 22 Orthopedic Regenerative Surgical Products market product outlook: Key takeaways
Fig. 23 Allograft market, 2017 - 2030 (USD Million)
Fig. 24 Amniotic products market, 2017 - 2030 (USD Million)
Fig. 25 Others market, 2017 - 2030 (USD Million)
Fig. 26 Synthetic market, 2017 - 2030 (USD Million)
Fig. 27 Cell-based market, 2017 - 2030 (USD Million)
Fig. 28 Viscosupplements market, 2017 - 2030 (USD Million)
Fig. 29 Orthopedic Regenerative Surgical Products market: Application movement analysis
Fig. 30 Orthopedic Regenerative Surgical Products market application outlook: Key takeaways
Fig. 31 Global orthopedic pain management market, 2017 - 2030 (USD million)
Fig. 32 Global trauma repair market, 2017 - 2030 (USD million)
Fig. 33 Global cartilage and tendon repair market, 2017 - 2030 (USD million)
Fig. 34 Global arthroplasty/joint reconstruction market, 2017 - 2030 (USD million)
Fig. 35 Global others market, 2017 - 2030 (USD million)
Fig. 36 Orthopedic Regenerative Surgical Products market: End-use movement analysis
Fig. 37 Orthopedic Regenerative Surgical Products market end-use outlook: Key takeaways
Fig. 38 Global hospitals market, 2017 - 2030 (USD million)
Fig. 39 Global ambulatory surgical centers market, 2017 - 2030 (USD million)
Fig. 40 Global others market, 2017 - 2030 (USD million)
Fig. 41 Regional outlook, 2021 & 2030
Fig. 42 Regional marketplace: Key takeaways
Fig. 43 North America orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 44 U.S. orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 45 Canada Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
Fig. 46 Europe orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 47 U.K. orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 48 Germany orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 49 France orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 50 Italy orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 51 Spain orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 52 Asia Pacific orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 53 Japan orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 54 China orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 55 India orthopedic regenerative surgical products market, 2017 - 2030 (USD Million)
Fig. 56 Latin America Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
Fig. 57 Brazil Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
Fig. 58 Mexico Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
Fig. 59 Argentina Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
Fig. 60 MEA Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
Fig. 61 South Africa Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
Fig. 62 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2017 - 2030 (USD Million)
Fig. 63 Market participant categorization
Fig. 64 Orthopedic regenerative surgical products: Company market position analysis
Fig. 65 Strategy mapping


More Publications